Previous 10 | Next 10 |
home / stock / vph:cc / vph:cc news
VALEO PHARMA TO HOST THIRD QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL , Sept. 9, 2022 /CNW Telbec/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical...
VALEO PHARMA ADDS PHARMACEUTICAL INDUSTRY VETERAN KYLE STEIGER TO LEADERSHIP TEAM Canada NewsWire Kyle Steiger appointed Senior Vice-President and Chief Commercial Officer Jean-François Fournier appointed new Business Unit Head - Ophthalm...
VALEO PHARMA CLOSES US$40 MILLION NON-DILUTIVE FINANCING FROM SAGARD HEALTHCARE PARTNERS Canada NewsWire Proceeds to fund acquisition of Canadian rights to 3 growing commercial stage drugs Acquisition allows Valeo to expand into Ophthalmology and Allergy ...
VALEO PHARMA ENTERS INTO LICENSE AGREEMENT WITH KALÉO FOR THE CANADIAN RIGHTS TO ALLERJECT® Canada NewsWire 700,000 Canadians suffering from severe allergies Canadian epinephrine auto-injector market exceeds $80M annually ALLERJE...
VALEO PHARMA ENTERS INTO AN AGREEMENT FOR OPHTHALMIC PRODUCTS, PrXIIDRA® AND PrSIMBRINZA®, IN CANADA Canada NewsWire Ophthalmology becomes additional strategic therapeutic area Significant market opportunities with more than 6 million 1 Canadian...
VALEO PHARMA TO HOST SECOND QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL , June 8, 2022 /CNW Telbec/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical...
Valeo Pharma Inc. Opens the Market Canada NewsWire TORONTO , May 9, 2022 /CNW/ - Steve Saviuk , Chief Executive Officer, Frederic Fasano , President and Chief Operating Officer, Luc Mainville , Senior Vice-President and Chief Financial Officer...
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS, APPOINTMENTS AND OPTIONS AND RSU GRANTS Canada NewsWire MONTREAL , April 28 , 2022 /CNW/ - Valeo Pharma Inc . (TSX:VPH) (OTCQB: VPHIF) (FSE:VP2) (" Valeo " or the " Company "), ...
VALEO PHARMA TO PRESENT AT THE 2022 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE VALEO PHARMA TO PRESENT AT THE 2022 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE Canada NewsWire MONTREAL , April 25, 2022 /CNW Telbec/ - Valeo Pharma I...
VALEO PHARMA ANNOUNCES LISTING OF CONVERTIBLE DEBENTURES ON TSX Canada NewsWire MONTREAL , April 19, 2022 /CNW Telbec/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, is p...
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
--News Direct-- Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million ...
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES Canada NewsWire Record Q2-24 revenues of $14.1 million , up 4% over Q2-23 outpacing revenue softness in several non-core brands Q2-24 adjusted EBITDA loss of $2.5 million compared to $1.7 million fo...